{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2 3\u2032-UTR",
      "antiviral defense",
      "hsa-miR-138-5p",
      "hsa-miR-3941"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34198800",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "6094",
      "10.3390/ijms22116094"
    ],
    "Journal": {
      "ISSN": "1422-0067",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "05"
        }
      },
      "Title": "International journal of molecular sciences",
      "ISOAbbreviation": "Int J Mol Sci"
    },
    "ArticleTitle": "In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3'-UTR.",
    "Abstract": {
      "AbstractText": [
        "COVID-19 pandemic is caused by betacoronavirus SARS-CoV-2. The genome of this virus is composed of a single strand of RNA with 5' and 3'-UTR flanking a region of protein-coding ORFs closely resembling cells' mRNAs. MicroRNAs are endogenous post-transcriptional regulators that target mRNA to modulate protein expression and mediate cellular functions, including antiviral defense. In the present study, we carried out a bioinformatics screening to search for endogenous human microRNAs targeting the 3'-UTR of SARS-CoV-2. Results from the computational techniques allowed us to identify 10 potential candidates. The capacity of 3 of them, together with hsa-miR-138-5p, to target the SARS-CoV-2 3'-UTR was validated in vitro by gene reporter assays. Available information indicates that two of these microRNAs, namely, hsa-miR-3941 and hsa-miR-138-5p, combine effective targeting of SARS-CoV-2 genome with complementary antiviral or protective effects in the host cells that make them potential candidates for therapeutic treatment of most, if not all, COVID-19 variants known to date. All information obtained while conducting the present analysis is available at Open Science Framework repository."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-4127-2101"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neuroprotection Group, Research Unit, National Hospital for Paraplegics (SESCAM), 45071 Toledo, Spain."
          }
        ],
        "LastName": "Barreda-Manso",
        "ForeName": "Mar\u00eda Asunci\u00f3n",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neuroprotection Group, Research Unit, National Hospital for Paraplegics (SESCAM), 45071 Toledo, Spain."
          }
        ],
        "LastName": "Nieto-D\u00edaz",
        "ForeName": "Manuel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neuroprotection Group, Research Unit, National Hospital for Paraplegics (SESCAM), 45071 Toledo, Spain."
          }
        ],
        "LastName": "Soto",
        "ForeName": "Altea",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neuroprotection Group, Research Unit, National Hospital for Paraplegics (SESCAM), 45071 Toledo, Spain."
          }
        ],
        "LastName": "Mu\u00f1oz-Galdeano",
        "ForeName": "Teresa",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neuroprotection Group, Research Unit, National Hospital for Paraplegics (SESCAM), 45071 Toledo, Spain."
          }
        ],
        "LastName": "Reigada",
        "ForeName": "David",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neuroprotection Group, Research Unit, National Hospital for Paraplegics (SESCAM), 45071 Toledo, Spain."
          }
        ],
        "LastName": "Maza",
        "ForeName": "Rodrigo M",
        "Initials": "RM"
      }
    ],
    "GrantList": [
      {
        "GrantID": "N.A.",
        "Agency": "Fondo Solidario COVID-19 of Globalcaja Foundation",
        "Country": ""
      },
      {
        "GrantID": "SBPLY/17/180501/000376",
        "Agency": "Consejer\u00eda de Educaci\u00f3n, Cultura y Deportes de Castilla-La Mancha government",
        "Country": ""
      },
      {
        "GrantID": "N.A.",
        "Agency": "Fundaci\u00f3n del Hospital Nacional de Parapl\u00e9jicos para la Investigaci\u00f3n y la Integraci\u00f3n (FUHNPAIIN)",
        "Country": ""
      },
      {
        "GrantID": "N.A.",
        "Agency": "European Union (FEDER) \"A way to make Europe\"",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Int J Mol Sci",
    "NlmUniqueID": "101092791",
    "ISSNLinking": "1422-0067"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "3' Untranslated Regions"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MIRN138 microRNA, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MIRN3941 microRNA, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MicroRNAs"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "3' Untranslated Regions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Base Sequence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Binding Sites"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genes, Reporter"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "MicroRNAs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Open Reading Frames"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sequence Alignment"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}